Evaxion to announce business update and third quarter 2024 financial results on october 31

Copenhagen, denmark, october 28, 2024 - evaxion biotech a/s (nasdaq: evax) (“evaxion”), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, will provide a business update and report its third quarter 2024 financial results on thursday october 31, 2024, before opening of the nasdaq cm.

EVAX Ratings Summary

EVAX Quant Ranking